Mitsubishi UFJ Asset Management
NGNE icon

Mitsubishi UFJ Asset Management’s Neurogene NGNE Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$192K Sell
6,090
-1,904
-24% -$52.4K ﹤0.01% 1023
2026
Q1 		$161K Sell
7,994
-198
-2% -$3.83K ﹤0.01% 1009
2025
Q4 		$165K Buy
+8,192
New +$204K ﹤0.01% 1043
2025
Q2 		– Sell
-11,231
Closed -$132K – 1636
2025
Q1 		$132K Buy
11,231
+941
+9% +$16.3K ﹤0.01% 1000
2024
Q4 		$239K Buy
10,290
+4,334
+73% +$161K ﹤0.01% 967
2024
Q3 		$250K Sell
5,956
-563
-9% -$21.8K ﹤0.01% 936
2024
Q2 		$237K Buy
+6,519
New +$230K ﹤0.01% 945

Other funds holding NGNE

SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Mitsubishi UFJ Asset Management's NGNE Position: Q2 2026 in Review

Mitsubishi UFJ Asset Management reduced its Neurogene (NGNE) stake by 24% in Q2 2026, selling an estimated $52.4K and leaving 6,090 shares worth $192K. The position accounts for ﹤0.01% of the portfolio, ranked #1023.

Mitsubishi UFJ Asset Management first reported a position in NGNE in Q2 2024 and has held it in 7 quarters since. The position peaked at $250K in Q3 2024. 112 funds tracked by Wall St. Rank hold NGNE as of Q2 2026.

  • Mitsubishi UFJ Asset Management held 6,090 shares of Neurogene worth $192K as of Q2 2026.
  • Mitsubishi UFJ Asset Management sold 1,904 Neurogene shares in Q2 2026, an estimated $52.4K.
  • Neurogene made up ﹤0.01% of Mitsubishi UFJ Asset Management's portfolio in Q2 2026, its #1023 holding.
  • Mitsubishi UFJ Asset Management first reported a position in Neurogene in Q2 2024 and has held it in 7 quarters since.
  • Mitsubishi UFJ Asset Management's Neurogene position peaked at $250K in Q3 2024.
  • 112 funds tracked by Wall St. Rank held Neurogene as of Q2 2026.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.